Medical devices, healthcare technology and the business of care
510(k) clearance · K253146

Hyperdrive 35 Guidewire

Rapid-Medical , Ltd. · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONK253146

What did the FDA decide?

On September 18, 2026, FDA recorded decision SESE for K253146, submitted by Rapid-Medical, Ltd. The listed device is the Hyperdrive 35 Guidewire, classified under product code DQX with a Cardiovascular specialty. In 510(k) terms, SESE denotes a substantially equivalent determination, which is a clearance rather than a PMA approval; the source data do not state whether the submission was a new original or a subsequent one.

The document excerpt describes the Hyperdrive 35 Guidewire as a 0.035-inch diameter steerable guidewire with a deflectable tip intended to aid in accessing vasculature. A separate passage in the same excerpt describes the Glidewire as designed to direct a catheter to a desired anatomical location in the peripheral vasculature during diagnostic or interventional procedures. The source does not establish whether the Glidewire is the predicate device, a comparator, or unrelated content, and it does not identify specific components, materials, or changes reviewed.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 18, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K253146
Regulatory pathway
510(k) premarket notification
Product code
DQX
Decision code
SESE
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wire, Guide, Catheter.

Product code
DQX
FDA device class
2

FDA decision timeline

  1. K253146 received

    Application receipt date recorded by FDA.

  2. K253146 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DQX

Product / regulatory recordCompanyPathwayDecision dateSource
Skycade Med Corporation510(k) clearanceOct 16, 2026FDA
Filmecc Co., Ltd.510(k) clearanceSep 3, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rapid-Medical , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Yokneam

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records